“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

September 15 - The heads of leading U.S. AI labs came together in a rare show of unity over the weekend to slow the technology's development, warning it could soon improve on its own and slip beyond ...

Top executives at three of the nation’s leading AI labs are calling for a slowdown in the development of advanced artificial intelligence. The comments are a rare display of consensus among competing ...

Researchers at OpenAI and Anthropic are publicly urging slower AI development, as debate grows over self-improving AI and its risks. Many concerns revolve around advanced models getting incredibly ...

【免费下载链接】freeCodeCamp freeCodeCamp.org's open-source codebase and curriculum. Learn math, programming, and computer science for free. 项目地址 ...

Choosing between RingCentral and Microsoft Teams comes down to one fact: RingCentral is built as a communications platform first, while Microsoft Teams is collaboration software with enterprise ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

This is an edition of The Wonder Reader, a newsletter in which our editors recommend a set of stories to spark your curiosity and fill you with delight. Sign up here to get it every Saturday morning.

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Prime Agent is an open-source self-improving coding and research agent (harness) released by Prime Intellect on August 5, 2026. It is built for coding workflows and long-running autonomous tasks. It ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...